Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone

Abdel-Hameed W. Al-Mistarehi • Shadi El-Akawi • Khalid A. Kheirallah,  et. al.DOI: 10.7759/cureus.67467  Abstract Background: Several medications have been proposed to manage COVID-19, with controversial data regarding their clinical benefits. We aimed to investigate the clinical…[...]

Read More

RED ALERT: Doctors Sound the Alarm After Fibrous Clots Discovered in Young Children Born to COVID-Vaxxed Mothers

by Jim Hᴏft  Top medical experts are raising alarm bells over the discovery of fibrous, prion-like clots in the blood of young children born to mothers who received the COVID-19 mRNA injections during…[...]

Read More

Inflammatory and Coagulation Marker Changes -Treated COVID-19 Patients

Akinari Tsukada • Daisuke Katagiri • Shinyu Izumi et. al., DOI: 10.7759/cureus.78836  Abstract Introduction Direct hemoperfusion using polymyxin B-immobilized polystyrene fiber column (PMX-DHP) removes endotoxin and inflammatory mediators from the blood. This study aimed to evaluate…[...]

Read More

Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids

Tony Kamel • William Toppen • Yasaman Salahmand DOI: 10.7759/cureus.85150  Abstract In December 2021, a 58-year-old unvaccinated woman with a past medical history of obesity presented to an outside hospital with severe coronavirus disease 2019…[...]

Read More